{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:25:44Z","timestamp":1787030744630,"version":"build-2736575974"},"reference-count":40,"publisher":"SLACK, Inc.","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Ann"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:p>\n                    Bronchiolitis is a viral lower respiratory tract infection primarily affecting children younger than 2 years; a common cause of health care encounters, including hospitalization; and a considerable economic burden for health care systems in the United States and worldwide. The American Academy of Pediatrics (AAP) most recently updated its bronchiolitis guideline in 2014 and reaffirmed supportive care as the mainstay of treatment. Despite these recommendations, there is still significant variability in care provided for these children, especially in bronchodilator usage, radiography, and high-flow nasal cannula. Since the 2014 AAP guideline, many pediatric hospitalists have undertaken quality initiatives to improve the adherence to published guidelines, yet a large gap remains between what is recommended and what is practiced. This article presents research on the efficacy of common interventions as well as an introduction to diagnostics and treatments potentially on the horizon.\n                    <jats:bold>\n                      [\n                      <jats:italic>Pediatr Ann<\/jats:italic>\n                      . 2024;53(6):e223\u2013e228.]\n                    <\/jats:bold>\n                  <\/jats:p>","DOI":"10.3928\/19382359-20240407-07","type":"journal-article","created":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T10:27:40Z","timestamp":1717928860000},"source":"Crossref","is-referenced-by-count":5,"title":["Bronchiolitis: Safely Doing Less Is the Next Big Thing"],"prefix":"10.3928","volume":"53","author":[{"given":"Amy","family":"Weis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Hailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-2742"},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms8101620"},{"key":"e_1_3_1_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.39884"},{"key":"e_1_3_1_5_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260809"},{"key":"e_1_3_1_6_2","doi-asserted-by":"publisher","DOI":"10.3928\/19382359-20170620-02"},{"key":"e_1_3_1_7_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12887-022-03206-4"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2006-2223"},{"key":"e_1_3_1_9_2","doi-asserted-by":"publisher","DOI":"10.15586\/aei.v49i1.12"},{"key":"e_1_3_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.25114"},{"key":"e_1_3_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.prrv.2019.04.003"},{"key":"e_1_3_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003123.pub3"},{"key":"e_1_3_1_13_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2015.36.3865"},{"key":"e_1_3_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.23928"},{"key":"e_1_3_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004878.pub4"},{"key":"e_1_3_1_16_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2015.36.3865"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004873.pub4"},{"key":"e_1_3_1_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004873.pub5"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004873.pub6"},{"key":"e_1_3_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004873.pub6"},{"key":"e_1_3_1_21_2","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.06470"},{"key":"e_1_3_1_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1714855"},{"key":"e_1_3_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30061-2"},{"key":"e_1_3_1_24_2","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3417"},{"key":"e_1_3_1_25_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2019-4083"},{"key":"e_1_3_1_26_2","doi-asserted-by":"publisher","DOI":"10.12788\/jhm.3520"},{"key":"e_1_3_1_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0000000000001664"},{"key":"e_1_3_1_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013552.pub2"},{"key":"e_1_3_1_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018657"},{"key":"e_1_3_1_30_2","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00268-2019"},{"key":"e_1_3_1_31_2","unstructured":"Highlights of Prescribing Information. US Food and Drug Administration. Updated July 2023. Accessed April 9 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/761328s000lbl.pdf"},{"key":"e_1_3_1_32_2","volume-title":"Healthcare providers: RSV prevention information","unstructured":"Healthcare providers: RSV prevention information. Centers for Disease Control and Prevention. Updated September 28, 2023. Accessed April 9, 2024. https:\/\/www.cdc.gov\/vaccines\/vpd\/rsv\/hcp\/child.html"},{"key":"e_1_3_1_33_2","unstructured":"American Academy of Pediatrics recommends medication to prevent RSV be given to all infants and urges equitable access. American Academy of Pediatrics. Published August 15 2023. Accessed April 9 2024. https:\/\/www.aap.org\/en\/news-room\/news-releases\/aap\/2023\/american-academy-of-pediatrics-recommends-medication-to-prevent-rsvbe-given-to-all-infants-and-urges-equitable-access\/"},{"key":"e_1_3_1_34_2","article-title":"August 21, 2023 Approval Letter -ABRYSVO (STN 125768)","author":"Kaslow DC","unstructured":"Kaslow DC. August 21, 2023 Approval Letter -ABRYSVO (STN 125768). US Food and Drug Administration. Published August 21, 2023. Accessed April 9, 2024. https:\/\/www.fda.gov\/media\/171492\/download?attachment","journal-title":"US Food and Drug Administration"},{"key":"e_1_3_1_35_2","volume-title":"Healthcare providers: RSV vaccination for pregnant people","unstructured":"Healthcare providers: RSV vaccination for pregnant people. Centers for Disease Control and Prevention. Updated September 29, 2023. Accessed April 9, 2024. https:\/\/www.cdc.gov\/vaccines\/vpd\/rsv\/hcp\/pregnant-people.html"},{"key":"e_1_3_1_36_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0900544"},{"key":"e_1_3_1_37_2","doi-asserted-by":"publisher","DOI":"10.4103\/2231-0770.133333"},{"key":"e_1_3_1_38_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00396"},{"key":"e_1_3_1_39_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-040816"},{"key":"e_1_3_1_40_2","unstructured":"Al-Ansari KM. Nebulized 5% hypertonic saline for the treatment of bronchiolitis. ClinicalTrials.gov. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT01016249"},{"key":"e_1_3_1_41_2","unstructured":"Pershad J. 7% hypertonic saline for acute bronchiolitis (HS). ClinicalTrials.gov. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT01871857"}],"container-title":["Pediatric Annals"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T10:27:50Z","timestamp":1717928870000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/19382359-20240407-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.3928\/19382359-20240407-07"],"URL":"https:\/\/doi.org\/10.3928\/19382359-20240407-07","relation":{},"ISSN":["0090-4481","1938-2359"],"issn-type":[{"value":"0090-4481","type":"print"},{"value":"1938-2359","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}